Southern Acids (M) Berhad (KLSE:SAB)
3.150
0.00 (0.00%)
At close: Jun 20, 2025
Southern Acids (M) Berhad Revenue
In the fiscal year ending March 31, 2025, Southern Acids (M) Berhad had annual revenue of 1.09B MYR with 18.51% growth. Southern Acids (M) Berhad had revenue of 248.27M in the quarter ending March 31, 2025, with 3.51% growth.
Revenue
1.09B
Revenue Growth
+18.51%
P/S Ratio
0.41
Revenue / Employee
624.95K
Employees
1,745
Market Cap
451.88M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1.09B | 170.31M | 18.51% |
Mar 31, 2024 | 920.22M | -186.52M | -16.85% |
Mar 31, 2023 | 1.11B | -74.14M | -6.28% |
Mar 31, 2022 | 1.18B | 434.96M | 58.31% |
Mar 31, 2021 | 745.93M | 79.83M | 11.98% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Malayan Banking Berhad | 28.16B |
Public Bank Berhad | 14.28B |
Tenaga Nasional Berhad | 65.70B |
CIMB Group Holdings Berhad | 20.86B |
IHH Healthcare Berhad | 24.72B |
Celcomdigi Berhad | 12.79B |
Press Metal Aluminium Holdings Berhad | 15.19B |
Hong Leong Bank Berhad | 6.67B |